Successful treatment with telaprevir of post-transplant fibrosing cholestatic hepatitis C in an HIV co-infected patient

Hepatitis C recurrence is the main cause of graft loss in liver transplant patients co-infected with human immunodeficiency virus (HIV). These patients have higher risk of fibrosing cholestatic hepatitis, which is the most severe type of hepatitis C recurrence. Until direct antiviral agents were rel...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Acta Gastroenterológica Latinoamericana
Huvudupphovsmän: Sebastián Marciano, Omar Andrés Galdame, Laura Alicia Barcan, Adrián Carlos Gadano
Materialtyp: Artigo
Språk:Inglês
Publicerad: Sociedad Argentina de Gastroenterología 2015
Ämnen:
Medicina
graft loss
protease inhibitors
hepatitis C recurrence
Direct antiviral agents
Länkar:https://www.redalyc.org/articulo.oa?id=199336842017
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk